Diabetes Flashcards
Normal blood sugar
80-100 fasting
Fasting blood sugar
After eating 170-200
HbA1c criteria for diagnosis
> or equal to 6.5
Random blood sugar
> 200
75 g 2 hours glucose tolerance test > or =
200
Patient had a fasting sugar of 127, what to do next?
Check hgba1c
Patient had a fasting blood sugar 118 and hgba1c of 6.5%, what to do next?
Recheck hgba1c
A 35 year old patient with bp 135/80 or X year old patient with bmi of 26 and sedentary or a 40 year old patient; what will you check next?
Screen for diabetes, fasting blood sugar
Patient had FBS of 129, repeat 127, this patient has…
DM and at risk for retinopathy and nephropathy now
40 year old patient with vitiligo diagnosed a year ago, FBS of 140, relatives have type II DM, BMI 23; what will you do next?
Check islet cell antibodies and anti glutamic acid decarboxylase antibodies
Sulfonylureas
Glimepiride (amaryl) Glipizide (glucotrol) glyburide (diabeta, micronase); avoid in obese
Meglitinides
Repaglinide; excreted through bile; hence drug of choice in CKD; rapid acting
Biguanides
Metformin (glucophage); decrease hepatic gluconeogenesis, decrease insulin resistance, decrease weight, decrease cholesterol/TG’s; Tx of choice in obese patients and increased TG’s; 5% with lactic acidosis; b12 deficiency
Alpha glucocidase inhibitors
Acarbose (precose); inhibits breakdown of carbohydrates and decreases absorption of glucose; mainly for post prandial hyperglycemia; avoid in low GFR
Thiazolidinediones ‘glitazones’
Pioglitazone (actos); avoid in patients with CHF NYHA II; thigh high edema, associated with bladder cancer
Incretin mimetics(glp-1 agonists)
Exenatide (bydureon), liraglutide (victoza-approved for weight loss bmi>30 and no DM), Dulaglutide (Trulicity), Semaglutide (ozempic): glp1 agonist, decreases hepatic gluconeogenesis, decreases gastric emptying, weight loss, increased cell growth
Liraglutide (victoza), Semaglutide (ozempic) and dulaglutide (trulicity)
Have shown to decrease CV risk; good agents for obese patients failing meds
DPP4 inhibitors
Sitagliptin (januvia), saxagliptin (onglyza)-potential CH risk, linagliptin (tradjenta) andd alogliptin (nesina)
Side effects of GLP 1 agonists
Nausea and pancreatitis; contraindications: pancreatitis, family hx of MEN IIA/IIB (medullary thyroid carcinoma)
Amylin analogue
Pramlinitide (symlin); slows gastric emptying, decreases glucagon secreation, weight loss and early satiety; complementary to insulin; no hypoglycemia; good for obese patients failing insulin therapy with high post prandial BS and gaining weight on short acting insulin agents
SGL2 Inhibitors
Canagliflozin (invokana), Dapagliflozin (farxiga), empaglifozin (jardiance); block reabsorption of glucose by kidney thereby increasing excretion of glucose in the urine
Dapagliflozin (farxiga)
Shown to reduce heart failure hospitalizations in diabetic patients
Empagliflozin (Jardiance) and Canagliflozin (invokana)
Reduced the incidence of end stage renal disease and hospitalizations for heart failure; there was also a trend toward decreased cardiovscular death and all cause mortality
Side effects of SGL2 inhibitors
Reduced blood pressure, genital mycotic infections, euglycemic ketoacidosis especially at times of extreme stress; necrotizing fascitis of perineum aka Fournier’s gangrene; for example; in a patient with pneumonia taking SGL2 inhibitors, stop it
ADA blood sugar goals in DM
hgba1c low risk of hypoglycemia <7%
hgba1c high risk of hypoglycemia 7-8%
hgba1c with terminal or comorbid conditions >8%
Preprandial glucose between 80-130
Peak 2 hours post prandial glucose <180
Patient with a bmi of 32, FBS is 115; family hx is significant for DM; best way to prevent onset of DM?
Diet and exercise; aerobics and resistance training
Drugs that cause hyperglycemia
Statins, beta blockers except coreg, hydrochlorothiazide, niacin, olanzapine, protease inhibitors, steroids
Patient with type II diabetes mellitus responded well to metformin and sulfonylura previously, for several years hgba1c 7% but now has increasing blood sugars for the past year; no infections; hgba1c 8.8%, what to do next?
Add 24 hour glargine insulin; progressive insulin deficiency not insulin resistance
In above patient, what drug do you intend to keep with insulin?
Biguanide aka metformin
The above patient does well on glargine insulin at bedtime and metformin for a year; hgba1c 8.5%, but FBS 115 to 130 range, what to do next?
Start lispro insulin